Cellectis (CLLS) Net Margin Growth (3y) (2018 - 2026)
Cellectis (CLLS) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 16,734.00 |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 130,766.00 |
| Mar 31, 2025 | 191,658.00 |
| Dec 31, 2024 | 29,016.00 |
| Sep 30, 2024 | 30,779.00 |
| Jun 30, 2024 | 4,370.00 |
| Mar 31, 2024 | 17,098.00 |
| Dec 31, 2023 | -1.45 Mn |
| Sep 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | -546,445.00 |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | 67,394.00 |
| Sep 30, 2022 | -1.61 Mn |
| Jun 30, 2022 | 145,381.00 |
| Mar 31, 2022 | -44,476.00 |
| Dec 31, 2021 | 214,019.00 |
| Sep 30, 2021 | 206,700.00 |
| Jun 30, 2021 | -27,021.00 |